Stocks
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (year values) |
||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | |||
| EV/EBITDA | ? | 15.1 | -8.51 | 1.62 | -0.13 | 277.4 | -39.5 | |
| Changes by years, y/y, % | -259% | -156% | -119% | -108% | -205 656% | |||
Blueprint Medicines Corporation. EV/EBITDA
Blueprint Medicines Corporation. EV/EBITDA, changes, %
Blueprint Medicines Corporation (BPMC) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2024Q1 | FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | LTM ? | |||
| EV/EBITDA | ? | 0.22 | 0.17 | -97.9 | 280.8 | -39.5 | -39.5 | |
| Changes by years, y/y, % | -106% | -103% | -6 809% | -197 034% | -17 853% | |||
| Changes by quarters, q/q, % | -256% | -25% | -58 619% | -387% | -114% | |||
